{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:50:51Z","timestamp":1789098651917,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ijpharm.2014.06.048","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T17:32:45Z","timestamp":1403890365000},"page":"369-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: In-vitro and in-vivo characterization"],"prefix":"10.1016","volume":"472","author":[{"given":"Nermeen Adel","family":"ElKasabgy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Hassen","family":"Elshafeey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.06.048_bib0005","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pathophys.2009.09.003","article-title":"Gastrointestinal lymphatics in health and disease","volume":"17","author":"Alexander","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2006.01.021","article-title":"Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions","volume":"313","author":"Bando","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","article-title":"SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization","volume":"391","author":"Basalious","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/17425247.2014.878701","article-title":"Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol","volume":"11","author":"Basavaraj","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0090-9556(25)00104-7","article-title":"Influence of dose on first-pass kinetics of 14C-imipramine in the isolated perfused rat liver","volume":"7","author":"Beaubien","year":"1979","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0169-409X(95)00105-G","article-title":"Lipophilic prodrugs designed for intestinal lymphatic transport","volume":"19","author":"Charman","year":"1996","journal-title":"Adv. Drug Del Rev."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0045","series-title":"The British Pharmacopoeia","author":"Commission","year":"2008"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF01062106","article-title":"Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat","volume":"6","author":"Dahlstrom","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jps.2600690716","article-title":"Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination","volume":"69","author":"de Boer","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cej.2010.11.062","article-title":"Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design","volume":"166","author":"de Lima","year":"2011","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2014.03.049","article-title":"Chitosan lactate wafer as a platform for the buccal delivery of tizanidine HCl: in vitro and in vivo performance","volume":"467","author":"El-Mahrouk","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10611869509015936","article-title":"Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence","volume":"3","author":"Florence","year":"1995","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0080","doi-asserted-by":"crossref","first-page":"045101","DOI":"10.1088\/0957-4484\/22\/4\/045101","article-title":"Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery","volume":"22","author":"Gonzalez-Mira","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejps.2012.07.006","article-title":"Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design","volume":"47","author":"Hao","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.22331","article-title":"Multidisciplinary approach on characterizing a mechanochemically activated composite of vinpocetine and crospovidone","volume":"100","author":"Hasa","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcis.2009.03.012","article-title":"Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)","volume":"334","author":"Helgason","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2009.10.010","article-title":"Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation","volume":"142","author":"Jensen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1166\/jcsb.2012.1020","article-title":"Preparation, characterization and applications of liposomes: state of the art","volume":"1","author":"Laouini","year":"2012","journal-title":"J. Colloid Sci. Biotechol."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0110","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2165\/00003495-199448020-00010","article-title":"Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension","volume":"48","author":"Lee","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1081\/DDC-100103731","article-title":"Preformulation studies on the S-isomer of oxybutynin hydrochloride, an improved chemical entity (ICE)","volume":"27","author":"Luner","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jps.20737","article-title":"Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride","volume":"96","author":"Mishra","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0125","series-title":"Clarke\u2019s Analysis of Drugs and Poisons","author":"Moffat","year":"2005"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-409X(00)00121-6","article-title":"Lymphatic targeting with nanoparticulate system","volume":"47","author":"Nishioka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(02)00051-9","article-title":"Lipid-based formulations for intestinal lymphatic delivery","volume":"15","author":"O'Driscoll","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/401747","article-title":"Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration","volume":"20","author":"Patel","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2014.05.019","article-title":"Montelukast-loaded nanostructured lipid carriers: part I Oral bioavailability improvement","author":"Patil-Gadhe","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0169-409X(01)00151-X","article-title":"Intestinal lymphatic drug transport: an update","volume":"50","author":"Porter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0155","series-title":"Handbook of Pharmaceutical Excipients","author":"Rowe","year":"2009"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1874343900802010006","article-title":"Interaction between n-octyl-b-d-thioglucopyranoside and bovine serum albumin","volume":"2","author":"Ruiz","year":"2008","journal-title":"Open Macromol. J."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2010.05.025","article-title":"Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine","volume":"395","author":"Rupp","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","author":"Ryan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0939-6411(02)00196-0","article-title":"A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles","volume":"55","author":"Shahgaldian","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08982104.2013.801489","article-title":"Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization","volume":"23","author":"Shamma","year":"2013","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/0975-1483.100020","article-title":"Optimization of pellets containing solid dispersion prepared by extrusion\/spheronization using central composite design and desirability function","volume":"4","author":"Singh","year":"2012","journal-title":"J. Young Pharm.: JYP"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1517\/17425247.2014.866088","article-title":"Lymphatic system: a prospective area for advanced targeting of particulate drug carriers","volume":"11","author":"Singh","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0195","first-page":"41","article-title":"Coating polymers for colon specific drug delivery: a comparative in vitro evaluation","volume":"53","author":"Sinha","year":"2003","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0200","series-title":"Experimental Design for Formulation","author":"Smith","year":"2005"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0205","series-title":"Pharmaceutics: The Science of Dosage Form Design","first-page":"198","article-title":"Powder flow","author":"Staniforth","year":"2002"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jpba.2008.04.018","article-title":"Ultra-performance liquid chromatography\u2013tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study","volume":"47","author":"Tang","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcis.2013.05.058","article-title":"Influence of metal oxide nanoparticles concentration on their zeta potential","volume":"407","author":"Wang","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0225","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1081\/DDC-120002842","article-title":"Preparation and characterization of camptothecin solid lipid nanoparticles","volume":"28","author":"Yang","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0235","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s12272-010-0614-6","article-title":"Preparation and in vitro evaluation of povidone-sodium cholate-phospholipid mixed micelles for the solubilization of poorly soluble drugs","volume":"33","author":"Zhu","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.06.048_bib0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.05.005","article-title":"Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability","volume":"394","author":"Zhuang","year":"2010","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314004773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314004773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T13:53:21Z","timestamp":1746280401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314004773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":48,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0378517314004773"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.048","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: In-vitro and in-vivo characterization","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.06.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}